GridAI Technologies Stock (NASDAQ:GRDX)

Revenue Ownership Financials Chart

Previous Close

$5.55

52W Range

$1.87 - $6.93

50D Avg

$4.21

200D Avg

$3.58

Market Cap

$38.65M

Avg Vol (3M)

$115.45K

Beta

1.68

Div Yield

-

GRDX Company Profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

GB

Employees

2

IPO Date

Oct 11, 2016

Website

GRDX Performance

GRDX Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$36.25K	-	-
Operating Income	$-7.08M	$-15.62M	$-15.77M
Net Income	$-6.55M	$-18.06M	$-15.79M
EBITDA	$-7.08M	$-15.57M	$-15.74M
Basic EPS	$-4.16	$-3.88	$-46.96
Diluted EPS	$-4.16	$-5.33	$-46.96

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
BCTX	BriaCell Therapeutics Corp.
CTXR	Citius Pharmaceuticals, Inc.
CING	Cingulate Inc.
CRIS	Curis, Inc.
ALLR	Allarity Therapeutics, Inc.
PCSA	Processa Pharmaceuticals, Inc.
ASBP	Aspire Biopharma Holdings, Inc.
ATHA	Athira Pharma, Inc.
LPTX	Leap Therapeutics, Inc.
PALI	Palisade Bio, Inc.